Hiding in plain sight: an illustrated pitfall of vasodilator stress testing in patients with liver cirrhosis

Ibrahim A, Schuster A, Alraies MC, Sonny A, Cywinski JB, Jaber WA. Liver transplant candidates: To stress or not to stress? Circulation 2014;130:A11773‐A11773.

Article  Google Scholar 

Gaduputi V, Abdulsamad M, Sakam S, Abbas N, Tariq H, Ihimoyan A. Systemic vascular resistance in cirrhosis: A predictor of severity? Hepat Med 2014;6:95‐101.

PubMed  PubMed Central  Google Scholar 

Abele JT, Raubenheimer M, Bain VG, Wandzilak G, AlHulaimi N, Coulden R. Quantitative blood flow evaluation of vasodilation-stress compared with dobutamine-stress in patients with end-stage liver disease using (82)Rb PET/CT. J Nucl Cardiol 2020;27:2048‐59.

Article  PubMed  Google Scholar 

Aljizeeri A, Alali Alfaris M, Ahmed D, Farea J, Elneama A, et al. Are patients with end-stage liver disease maximally vasodilated? Insights from Rubidium-82 PET dilatory perfusion. JACC Cardiovasc Imaging 2019;12:2583‐4.

Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif